Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Companies
Results 1 - 1 out of 1 displayed.
Search filter:
- Search for: Company
Headquarters
Berkeley, California, USA
Berkeley, California, USA
| Main sector: |
|
| Subsector: |
|
| Indications: |
|
| Employees: |
|
| Products: |
|
Description:
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve antitumor activity. CB-010 is the company's lead clinical-stage program is an allogeneic anti-CD19 CAR-T cell therapy for the treatment of patients...
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve antitumor activity. CB-010 is the company's lead clinical-stage program is an allogeneic anti-CD19 CAR-T cell therapy for the treatment of patients...
Company
|
Therapeutics
|
Technologies
|
Clinical trials
|
License agreements
|
Financing rounds
|
Management
|
Financials
Already have a valid Biotechgate account? Login here »
Get access to Biotechgate
Download complete company profiles
including product pipelines, financing rounds and management
details.